TrialClinical cardiology2020

Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial.

Zhiqiang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.